Drug maker releases GLP-1 in cheaper pill form
Of the nearly 78,000 souls who reside in Grays Harbor County, 10% are diabetic. That’s nearly 7,800 people living with either Type 1 or Type 2 diabetes. Data USA reports…
Of the nearly 78,000 souls who reside in Grays Harbor County, 10% are diabetic. That’s nearly 7,800 people living with either Type 1 or Type 2 diabetes. Data USA reports…
MedWatchUS FDA grants priority review for Sanofi’s type 1 diabetes drugFrance is seeking fast-track approval of diabetes drug Tzield in children aged over one..2 hours ago
Sanofi could be months away from wider US approval for Tzield, its first-in-class drug for delaying the progression of type 1 diabetes (T1D), in children as young as one. The…
Polisan has initiated an international clinical trial to evaluate Citoflavin (inosine/nicotinamide/riboflavin/succinic acid) for the treatment of diabetic polyneuropathy, a common complication of diabetes. According to the company’s press service, the…
Scientists in Sweden have created a new pill designed to help the body burn fat and control blood sugar in a different way than popular GLP-1 drugs, like Ozempic. While injectable GLP-1s…
Drugmaker Cipla on Wednesday said it has launched a medication for managing obesity and type-2 diabetes mellitus. The company has launched Yurpeak (tirzepatide), a one-weekly injectable therapy for obesity and…
With buzzy medications like Ozempic and Mounjaro making headlines for blood sugar management, it’s easy to forget that some medications have been helping patients with type 2 diabetes for decades.…
With buzzy medications like Ozempic and Mounjaro making headlines for blood sugar management, it’s easy to forget that some medications have been helping patients with type 2 diabetes for decades.…
Chronicle-TribuneSchools, local businesses partner to promote healthy living through DATA Quiz BowlStudents from around Grant County competed this week in the annual Grant County Drug, Alcohol and Tobacco Awareness (DATA)…
Credit: Artem Podrez from Pexels A Garvan-led clinical trial has found that using a common and inexpensive type 2 diabetes drug reduces insulin needs in type 1 diabetes, opening doors…